{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:19:33Z","timestamp":1786403973006,"version":"build-2736575974"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ijwd.2021.01.021","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T16:14:38Z","timestamp":1611936878000},"page":"290-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Urticarial vasculitis"],"prefix":"10.1097","volume":"7","author":[{"given":"Stephanie L.","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Jorizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"4","key":"10.1016\/j.ijwd.2021.01.021_b0005","first-page":"929","article-title":"Renal manifestations in hypocomplementic urticarial vasculitis syndrome: Is it a distinct pathology?","volume":"28","author":"AlHermi","year":"2017","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.ijwd.2021.01.021_b0010","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s10067-019-04548-8","article-title":"Exceptional association of hypocomplementemic urticarial vasculitis syndrome (HUVS) and symptomatic pulmonary histoplasmosis: A case-based literature review","volume":"38","author":"Alomari","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ijwd.2021.01.021_b0015","series-title":"Leukocytoclastic vasculitis","author":"Baigrie","year":"2020"},{"key":"10.1016\/j.ijwd.2021.01.021_b0020","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1136\/annrheumdis-2019-215605","article-title":"Dramatic but suspensive effect of interleukin-1 inhibitors for persistent urticarial vasculitis: A French multicentre retrospective study","volume":"78","author":"Bettuzzi","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijwd.2021.01.021_b0025","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3389\/fimmu.2019.00546","article-title":"Skin and systemic inflammation in Schnitzler's syndrome are associated with neutrophil extracellular trap formation","volume":"10","author":"Bonnekoh","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ijwd.2021.01.021_b0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2133.2000.03624.x","article-title":"Methotrexate-induced exacerbation of urticarial vasculitis: An unusual adverse reaction","volume":"143","author":"Borcea","year":"2000","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.ijwd.2021.01.021_b0035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/03009740600938647","article-title":"Non-complementaemic urticarial vasculitis: Successful treatment with the IL-1 receptor antagonist, anakinra","volume":"36","author":"Botsios","year":"2007","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.ijwd.2021.01.021_b0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.nephro.2019.09.004","article-title":"N\u00e9phropathie associ\u00e9e \u00e0 une vascularite urticarienne hypocompl\u00e9ment\u00e9mique : pr\u00e9sentation d\u2019un cas clinique et revue de la litt\u00e9rature [Nephropathy associated with hypocomplementemic urticarial vasculitis: A case report and literature review]","volume":"16","author":"Boyer","year":"2020","journal-title":"Nephrol Ther"},{"issue":"1","key":"10.1016\/j.ijwd.2021.01.021_b0045","first-page":"36","article-title":"Hypocomplementemic urticarial vasculitis syndrome: A case report and literature review","volume":"5","author":"Buck","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2021.01.021_b0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2500\/aap.2007.28.2972","article-title":"Urticarial vasculitis","volume":"28","author":"Chang","year":"2007","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.ijwd.2021.01.021_b0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40413-015-0059-y","article-title":"Urticarial vasculitis induced by OTC diet pills: A case report","volume":"8","author":"Ch\u00e9rrez Ojeda","year":"2015","journal-title":"World Allergy Organ J"},{"issue":"1","key":"10.1016\/j.ijwd.2021.01.021_b0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12895-018-0077-x","article-title":"Patient-reported outcomes in urticarial vasculitis treated with omalizumab: Case report","volume":"18","author":"Cherrez-Ojeda","year":"2018","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.ijwd.2021.01.021_b0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13223-019-0339-0","article-title":"Autoimmune thyroid disease and urticarial vasculitis: Is there a significant association?","volume":"15","author":"Cherrez-Ojeda","year":"2019","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"5","key":"10.1016\/j.ijwd.2021.01.021_b0070","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/09546630801961067","article-title":"An urticarial vasculitis case induced by glatiramer acetate","volume":"19","author":"Cicek","year":"2008","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.ijwd.2021.01.021_b0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1590\/abd1806-4841.20131532","article-title":"Evaluation of D-dimer serum levels among patients with chronic urticaria, psoriasis and urticarial vasculitis","volume":"88","author":"Criado","year":"2013","journal-title":"An Bras Dermatol"},{"issue":"3","key":"10.1016\/j.ijwd.2021.01.021_b0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0190-9622(08)81944-5","article-title":"Clinical pearl: Diascopy helps diagnose urticarial vasculitis","volume":"30","author":"Dahl","year":"1994","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.ijwd.2021.01.021_b0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/DAD.0000000000001501","article-title":"Dermal C4d deposition and neutrophil alignment along the dermal\u2013epidermal junction as a diagnostic adjunct for hypocomplementemic urticarial vasculitis (anti-C1q vasculitis) and underlying systemic disease","volume":"42","author":"Damman","year":"2020","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.ijwd.2021.01.021_b0090","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaip.2018.05.006","article-title":"Mimickers of urticaria: Urticarial vasculitis and autoinflammatory diseases","volume":"6","author":"Davis","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ijwd.2021.01.021_b0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13601-018-0222-y","article-title":"Normocomplementaemic urticarial vasculitis: Effective treatment with omalizumab","volume":"8","author":"de Brito","year":"2018","journal-title":"Clin Transl Allergy"},{"issue":"10","key":"10.1016\/j.ijwd.2021.01.021_b0100","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1111\/jdv.16713","article-title":"Urticarial vasculitis in COVID-19 infection: A vasculopathy-related symptom?","volume":"34","author":"de Perosanz-Lobo","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.ijwd.2021.01.021_b0105","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1468-3083.2007.02641.x","article-title":"Clinicopathologic profile of normocomplementemic and hypocomplementemic urticarial vasculitis: A study from South India","volume":"22","author":"Dincy","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijwd.2021.01.021_b0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/PLMI.S69414","article-title":"Schnitzler syndrome: Clinical features and histopathology","volume":"7","author":"Dingli","year":"2015","journal-title":"Pathol Lab Med Int"},{"issue":"3","key":"10.1016\/j.ijwd.2021.01.021_b0115","first-page":"495","article-title":"Paraneoplastic urticarial vasculitis and renal carcinoma","volume":"13","author":"Ducarme","year":"2003","journal-title":"Prog Urol"},{"issue":"3","key":"10.1016\/j.ijwd.2021.01.021_b0120","first-page":"34","article-title":"Urticaria multiforme","volume":"6","author":"Emer","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2021.01.021_b0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/ced.13076","article-title":"Effectiveness of omalizumab in a case of urticarial vasculitis","volume":"42","author":"Fueyo-Casado","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ijwd.2021.01.021_b0130","article-title":"Methotrexate combined with omalizumab for difficult to treat urticaria: A further step-up treatment?","author":"Garbayo-Salmons","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ijwd.2021.01.021_b0135","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1038\/s41598-020-63146-w","article-title":"Development of a clinical-dermoscopic model for the diagnosis of urticarial vasculitis","volume":"10","author":"Garc\u00eda-Garc\u00eda","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijwd.2021.01.021_b0140","first-page":"1","article-title":"Normocomplementemic urticarial vasculitis associated with A\/H1N1 in a child Case report","volume":"25","author":"G\u00f6k\u00e7e","year":"2020","journal-title":"SN Compr Clin Med"},{"issue":"2","key":"10.1016\/j.ijwd.2021.01.021_b0145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.revmed.2017.03.005","article-title":"Hypocomplementemic urticarial vasculitis","volume":"39","author":"Jachiet","year":"2018","journal-title":"Rev Med Interne"},{"issue":"2","key":"10.1016\/j.ijwd.2021.01.021_b0150","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/art.38956","article-title":"The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: Data from a French nationwide study of fifty-seven patients","volume":"67","author":"Jachiet","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.ijwd.2021.01.021_b0155","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11926-009-0060-y","article-title":"Hypocomplementemic urticarial vasculitis syndrome","volume":"11","author":"Jara","year":"2009","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"10.1016\/j.ijwd.2021.01.021_b0160","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/ijd.14387","article-title":"Eosinophilic infiltration: An under-reported histological finding in urticarial vasculitis","volume":"58","author":"Kamyab","year":"2019","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2021.01.021_b0165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/ced.12553","article-title":"A 14-year paraneoplastic rash: Urticarial vasculitis and dermal binding bullous pemphigoid secondary to chronic lymphocytic leukaemia","volume":"40","author":"Kassim","year":"2015","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.ijwd.2021.01.021_b0170","first-page":"223","article-title":"Urticarial vasculitis in infancy","volume":"69","author":"Kaur","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1016\/j.ijwd.2021.01.021_b0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4168\/aair.2010.2.1.55","article-title":"Cutaneous leukocytoclastic vasculitis due to anti-tuberculosis medications, rifampin and pyrazinamide","volume":"2","author":"Kim","year":"2010","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.ijwd.2021.01.021_b0180","doi-asserted-by":"crossref","unstructured":"Ko\u00e7 E, Aksoy B, Tatl\u0131parmak A. Urticarial vasculitis [Internet] 2017 [cited 17 June 2020]. Available from: https:\/\/www.intechopen.com\/books\/a-comprehensive-review-of-urticaria-and-angioedema\/urticarial-vasculitis","DOI":"10.5772\/68109"},{"issue":"1","key":"10.1016\/j.ijwd.2021.01.021_b0185","first-page":"49","article-title":"Urticarial vasculitis in an infant","volume":"81","author":"Koch","year":"2008","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.ijwd.2021.01.021_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100107","article-title":"Management of urticarial vasculitis: A worldwide physician perspective","volume":"13","author":"Kolkhir","year":"2020","journal-title":"World Allergy Organ J"},{"issue":"2","key":"10.1016\/j.ijwd.2021.01.021_b0195","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaci.2018.09.007","article-title":"Treatment of urticarial vasculitis: A systematic review","volume":"143","author":"Kolkhir","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.ijwd.2021.01.021_b0200","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/0378-6323.148586","article-title":"Enalapril induced normocomplementemic urticarial vasculitis","volume":"81","author":"Koregol","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"10.1016\/j.ijwd.2021.01.021_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.04.008","article-title":"Efficacy and safety of canakinumab in urticarial vasculitis: An open-label study","volume":"132","author":"Krause","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.ijwd.2021.01.021_b0210","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jaad.2006.10.962","article-title":"Prolonged urticaria with purpura: The spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis","volume":"56","author":"Lee","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2021.01.021_b0215","doi-asserted-by":"crossref","first-page":"560","DOI":"10.4103\/0253-7613.165180","article-title":"Telmisartan induced urticarial vasculitis","volume":"47","author":"Mahajan","year":"2015","journal-title":"Indian J Pharmacol"},{"issue":"4","key":"10.1016\/j.ijwd.2021.01.021_b0220","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4103\/0019-5154.135546","article-title":"Levetiracetam induced urticarial vasculitis: A preliminary report","volume":"59","author":"Mangal","year":"2014","journal-title":"Indian J Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2021.01.021_b0225","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/archderm.134.1.88","article-title":"Pathophysiology of urticarial vasculitis","volume":"134","author":"Mehregan","year":"1998","journal-title":"Arch Dermatol"},{"issue":"3 Pt 2","key":"10.1016\/j.ijwd.2021.01.021_b0230","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0190-9622(92)70069-R","article-title":"Urticarial vasculitis: A histopathologic and clinical review of 72 cases","volume":"26","author":"Mehregan","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.ijwd.2021.01.021_b0235","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/ijd.15112","article-title":"Urticarial vasculitis in a COVID-19 recovered patient","volume":"59","author":"Nasiri","year":"2020","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.ijwd.2021.01.021_b0240","doi-asserted-by":"crossref","first-page":"382","DOI":"10.18176\/jiaci.0191","article-title":"A case of hypocomplementemic urticarial vasculitis syndrome successfully treated with omalizumab","volume":"27","author":"Nucera","year":"2017","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"2","key":"10.1016\/j.ijwd.2021.01.021_b0245","first-page":"166","article-title":"Urticarial vasculitis","volume":"14","author":"O'Donnell","year":"1995","journal-title":"Int Angiol"},{"issue":"8","key":"10.1016\/j.ijwd.2021.01.021_b0250","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/art.38010","article-title":"DNASE1L3 mutations in hypocomplementemic urticarial vasculitis syndrome","volume":"65","author":"Oz\u00e7akar","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.ijwd.2021.01.021_b0255","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00296-010-1645-5","article-title":"Hypocomplementemic urticarial vasculitis syndrome in three siblings","volume":"33","author":"Oz\u00e7akar","year":"2013","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.ijwd.2021.01.021_b0260","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1365-4632.2010.04684.x","article-title":"Cold-induced urticarial vasculitis","volume":"51","author":"P\u00e9rez-Bustillo","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ijwd.2021.01.021_b0265","doi-asserted-by":"crossref","first-page":"285","DOI":"10.11604\/pamj.2016.24.285.8168","article-title":"Atteinte pulmonaire s\u00e9v\u00e8re au cours de la vascularite hypocompl\u00e9ment\u00e9mique urticarienne [Severe pulmonary involvement in hypocomplementemic urticarial vasculitis (HUV)]","volume":"24","author":"Raoufi","year":"2016","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.ijwd.2021.01.021_b0270","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-009082","article-title":"Hypocomplementaemic urticarial vasculitis syndrome: A mimicker of systemic lupus erythematosus","volume":"2013","author":"Roy","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.ijwd.2021.01.021_b0275","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2340\/00015555-1653","article-title":"Urticarial vasculitis associated with essential thrombocythaemia","volume":"94","author":"Scott","year":"2014","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.ijwd.2021.01.021_b0280","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2133.2007.07983.x","article-title":"Hypocomplementaemic urticarial vasculitis associated with non-Hodgkin lymphoma and treatment with intravenous immunoglobulin","volume":"157","author":"Shah","year":"2007","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.ijwd.2021.01.021_b0285","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/rheumatology\/key110","article-title":"Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis)","volume":"57","author":"Sj\u00f6wall","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ijwd.2021.01.021_b0290","first-page":"36","article-title":"Methotrexate for urticarial vasculitis","volume":"72","author":"Stack","year":"1994","journal-title":"Ann Allergy"},{"issue":"8","key":"10.1016\/j.ijwd.2021.01.021_b0295","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00105-007-1301-5","article-title":"Hypokomplement\u00e4misches Urtikaria-Vaskulitis-Syndrom. Erfolgreiche Therapie mit intraven\u00f6sen Immunglobulinen [Hypocomplementemic urticarial vasculitis syndrome. Successful therapy with intravenous immunoglobulins]","volume":"58","author":"Staubach-Renz","year":"2007","journal-title":"Hautarzt"},{"issue":"5","key":"10.1016\/j.ijwd.2021.01.021_b0300","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/RHU.0b013e3182288400","article-title":"Refractory urticarial vasculitis as a complication of ulcerative colitis successfully treated with rituximab","volume":"17","author":"Swaminath","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.ijwd.2021.01.021_b0305","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/ijd.12868","article-title":"Hypocomplementemic urticarial vasculitis arising in a patient with immunoglobulin G4-related disease","volume":"55","author":"Takao","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ijwd.2021.01.021_b0310","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bjd.13296","article-title":"IgG4-related skin disease","volume":"171","author":"Tokura","year":"2014","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2021.01.021_b0315","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jfma.2018.01.022","article-title":"Acute respiratory distress syndrome in a man with Epstein-Barr virus infection-induced hypocomplementemic urticarial vasculitis","volume":"117","author":"Tsai","year":"2018","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"10.1016\/j.ijwd.2021.01.021_b0320","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1385\/CRIAI:23:2:201","article-title":"Urticarial vasculitis","volume":"23","author":"Venzor","year":"2002","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"10.1016\/j.ijwd.2021.01.021_b0325","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2169\/internalmedicine.50.4515","article-title":"Hypocomplementemic urticarial vasculitis syndrome is associated with high levels of serum IgG4: A clinical manifestation that mimics IgG4-related disease","volume":"50","author":"Wakamatsu","year":"2011","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.ijwd.2021.01.021_b0330","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/rheumatology\/41.4.476","article-title":"Urticarial vasculitis: A paraneoplastic presentation of B-cell non-Hodgkin's lymphoma","volume":"41","author":"Wilson","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.ijwd.2021.01.021_b0335","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/art.1780370718","article-title":"Hypocomplementemic urticarial vasculitis syndrome in identical twins","volume":"37","author":"Wisnieski","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ijwd.2021.01.021_b0340","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00002281-200001000-00005","article-title":"Urticarial vasculitis","volume":"12","author":"Wisnieski","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ijwd.2021.01.021_b0345","article-title":"Urticarial vasculitis-associated intestinal ischemia","volume":"2016","author":"Wong","year":"2016","journal-title":"Case Rep Gastrointest Med"},{"issue":"4","key":"10.1016\/j.ijwd.2021.01.021_b0350","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1525-1470.2009.00950.x","article-title":"Intravenous immunoglobulin therapy for hypocomplementemic urticarial vasculitis associated with systemic lupus erythematosus in a child","volume":"26","author":"Yamazaki-Nakashimada","year":"2009","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2021.01.021_b0355","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4081\/reumatismo.2018.1052","article-title":"Urticarial vasculitis as an initial manifestation of colonic carcinoma: A case report and review of the literature","volume":"70","author":"Younis","year":"2018","journal-title":"Reumatismo"},{"issue":"1","key":"10.1016\/j.ijwd.2021.01.021_b0360","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.iac.2013.09.007","article-title":"Urticarial vasculitis and Schnitzler syndrome (published correction appears in Immunol Allergy Clin North Am 2014;34(2):xix. Zuberbier, HC Torsten [corrected to Zuberbier, Torsten])","volume":"34","author":"Zuberbier","year":"2014","journal-title":"Immunol Allergy Clin North Am"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647521000241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647521000241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T14:25:17Z","timestamp":1641565517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647521000241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2352647521000241"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2021.01.021","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urticarial vasculitis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2021.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}